TWC
INM icon

TD Waterhouse Canada’s InMed Pharmaceuticals INM Stock Holding History

TD Waterhouse Canada’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$21 – 1976
2024
Q2 		$21 Buy
+4
New +$23 ﹤0.01% 1886
2024
Q1 		– Sell
-4
Closed -$43 – 1848
2023
Q4 		$43 Hold
4
– – ﹤0.01% 1678
2023
Q3 		$76 Hold
4
– – ﹤0.01% 1668
2023
Q2 		$103 Hold
4
– – ﹤0.01% 1702
2023
Q1 		$125 Hold
4
– – ﹤0.01% 1694
2022
Q4 		$252 Hold
4
– – ﹤0.01% 1636
2022
Q3 		$757 Hold
4
– – ﹤0.01% 1602
2022
Q2 		$1.26K Hold
4
– – ﹤0.01% 1599
2022
Q1 		$2.42K Hold
4
– – ﹤0.01% 1569
2021
Q4 		$3.68K Buy
+4
New +$3.1K ﹤0.01% 1495

Other funds holding INM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

TD Waterhouse Canada's INM Position: Q3 2024 in Review

TD Waterhouse Canada sold out of InMed Pharmaceuticals (INM) in Q3 2024, closing a stake of 4 shares — an estimated $21 sold.

TD Waterhouse Canada first reported a position in INM in Q4 2021 and held it in 10 quarters. The position peaked at $3.68K in Q4 2021. 13 funds tracked by Wall St. Rank hold INM as of Q3 2024.

  • TD Waterhouse Canada reported no remaining InMed Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 4 InMed Pharmaceuticals shares in Q3 2024, an estimated $21.
  • TD Waterhouse Canada first reported a position in InMed Pharmaceuticals in Q4 2021 and held it in 10 quarters.
  • TD Waterhouse Canada's InMed Pharmaceuticals position peaked at $3.68K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q3 2024.

Based on TD Waterhouse Canada's 13F filing for Q3 2024, filed 12 Nov 2024.